Position in QTRX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$0
-$5,105,876 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
6 quarters on record
Common Shares in QTRX Over Time
Shares Held
Position Value (USD)
Derivatives in QTRX
reported options exposure · as of Jun 30, 2026CallValue
$1,123,200
CallShares
260,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Medical Devices
Healthcare · as of Jun 30, 2026Balyasny Asset Management L.P. holds $729,959,673 across 38 Medical Devices names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PEN |
Penumbra Inc
|
1,090,163 | $344,218,967 | |
| 2 | MDT |
Medtronic plc
|
986,367 | $77,163,489 | |
| 3 | GKOS |
GLAUKOS Corp
|
491,636 | $68,711,047 | |
| 4 | ABT |
Abbott Laboratories
|
740,808 | $67,220,917 | |
| 5 | EW |
Edwards Lifesciences Corp
|
456,202 | $41,268,032 | |
| 6 | 739,829 | $18,406,945 | |||
| 7 | BBNX |
Beta Bionics, Inc.
|
855,682 | $13,408,536 | |
| 8 | AXGN |
Axogen, Inc.
|
253,498 | $11,709,072 |
All Filings in QTRX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,123,200 | 260,000 | Call | Sole | 2026-08-14 | |
| 2025-06-30 | $5,105,876 | 767,801 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $289,734 | 44,506 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $325,596 | 30,630 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $537,852 | 41,501 | Shares | Sole | 2024-11-14 | |
| 2023-12-31 | $779,080 | 28,496 | Shares | Sole | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||